StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)

Close on Nov 18, 2026Market cap $288.48MP/E –Yield –

Benitec Biopharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Benitec Biopharma's enterprise value was $145.96M on Nov 11, 2026, against $245.73M a year earlier. Over the last 5 years it ranged from $2.37M to $1.62B, with a median of $226.76M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$145.96M-43.7%
2025Dec 31, 2025$259.11M-72.7%
2024Dec 31, 2024$949.09M+8412.0%
2023Dec 29, 2023$11.15M-96.5%
2022Dec 30, 2022$319.13M-80.3%
2021Dec 31, 2021$1.62B+556.9%
2020Dec 31, 2020$246.94M-49.2%
2019Dec 31, 2019$485.71M–

More Benitec Biopharma figures

See a number that looks wrong?